Neuroimaging and neurochemistry of autism

Pediatric Clinics of North America

Volumn 59, Issue 1, 2012, Pages 63-73

  Chugani, Diane C ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dopamine; GABA; Magnetic resonance spectroscopy (MRS); N acetylaspartate; Positron emission tomography (PET); Receptors; Serotonin; Single photon emission computed tomography (SPECT)

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; DOPAMINE TRANSPORTER; GLUTAMIC ACID; GLUTAMINE; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER;

AUTISM; COMPUTER PROGRAM; GENETIC ASSOCIATION; HUMAN; NEUROCHEMISTRY; NEUROIMAGING; NEUROTRANSMISSION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADOLESCENT; BRAIN CHEMISTRY; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; HUMANS; INFANT; MAGNETIC RESONANCE SPECTROSCOPY; NEUROIMAGING; NEUROTRANSMITTER AGENTS; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84856300815     PISSN: 00313955     EISSN: 15578240     Source Type: Journal    
DOI: 10.1016/j.pcl.2011.10.002     Document Type: Review

References (54)

1. Bill B.R., Geschwind D.H. Genetic advances in autism: heterogeneity and convergence on shared pathways. Curr Opin Genet Dev 2009, 19(3):271-278.
2. Anagnostou E., Taylor M.J. Review of neuroimaging in autism spectrum disorders:what have we learned and where we go from here. Mol Autism 2011, 2(1):4-9.
3. Sivaswamy L., Chugani D.C. Positron emission tomography. Textbook of autism spectrum disorders 2011, 395-408. American Psychiatric Publishing, Washington, DC. E. Hollander, A. Kolevzon, J.T. Coyle (Eds.).
4. Hoffman E.J., Phelps M.E. Positron emission tomography: principles and quantitation. Positron emission tomography and autoradiography: principles and applications for the brain and heart 1986, 237-286. Raven Press, New York. M.E. Phelps, J.C. Mazziotta, H.R. Schelbert (Eds.).
5. Ter-Pogossian M.M. Positron emission tomography. Principles of nuclear medicine 1995, 342-346. WB Saunders, London. H.N. Wagner, Z. Szabo, J.W. Buchanan (Eds.).
6. Kuhl D.E., Edwards R.Q., Ricci A.R., et al. Quantitative section scanning using orthogonal tangent correction. JNucl Med 1973, 14:196-200.
7. Iwata R. Reference book for PET Radiopharmaceuticals. 2004. Available at: Accessed June, 2011. http://kakuyaku.cyric.tohoku.ac.jp/indexe.html.
8. Shiue C.Y., Welch M.J. Update on PET radiopharmaceuticals: life beyond fluorodeoxyglucose. Radiol Clin North Am 2004, 42(6):1033-1053.
9. Smith G.S., Koppel J., Goldberg S. Applications of neuroreceptor imaging to psychiatry research. Psychopharmacol Bull 2003, 37(4):26-65.
10. Gjedde A., Wong D.F., Rosa-Neto P., et al. Mapping neuroreceptors at work: on the definition and interpretation of binding potentials after 20 years of progress. Int Rev Neurobiol 2005, 63:1-20.
11. MacLaren D.C., Toyokuni T., Cherry S.R., et al. PET imaging of transgene expression. Biol Psychiatry 2000, 48(5):337-348.
12. Jain M., Batra S.K. Genetically engineered antibody fragments and PET imaging: a new era of radioimmunodiagnosis. JNucl Med 2003, 44(12):1970-1972.
13. Weissleder R., Mahmood U. Molecular imaging. Radiology 2001, 219(2):316-333.
14. Pardridge W.M. Molecular biology of the blood-brain barrier. Mol Biotechnol 2005, 30(1):57-70.
15. Ernst M., Zamatkin A.J., Matochik J.A., et al. Low medial prefrontal dopaminergic activity in autistic children. Lancet 1997, 350(9078):638.
16. Xiao-Mian S., Jing Y., Chongxuna Z., et al. Study of 99mTc-TRODAT-1 imaging on human brain with children autism by single photon emission computed tomography. Conf Proc IEEE Eng Med Biol Soc 2005, 5:5328-5330.
17. Nakamura K., Sekine Y., Ouchi Y., et al. Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Arch Gen Psychiatry 2010, 67(1):59-68.
18. Makkonen I., Riikonen R., Kokki H., et al. Serotonin and dopamine transporter binding in children with autism determined by SPECT. Dev Med Child Neurol 2008, 50(8):593-597.
19. Schain R.J., Freedman D.X. Studies on 5-hydoxyindole metabolism in autism and other mentally retarded children. JPediatrics 1961, 59:315-320.
20. Chugani D.C., Muzik O., Rothermel R., et al. Altered serotonin synthesis in the dentatothalamo-cortical pathway in autistic boys. Ann Neurol 1997, 14:666-669.
21. Diksic M., Nagahiro S., Sourkes T.L., et al. Anew method to measure brain serotonin synthesis invivo. I. Theory and basic data for a biological model. JCereb Blood Flow Metab 1990, 9:1-12.
22. Chugani D.C., Muzik O., Behen M., et al. Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann Neurol 1999, 45(3):287-295.
23. Chandana S.R., Behen M.E., Juhasz C., et al. Significance of abnormalities in developmental trajectory and asymmetry of cortical serotonin synthesis in autism. Int J Dev Neurosci 2005, 23:171-182.
24. Murphy D.G., Daly E., Schmitz N., et al. Cortical serotonin 5-HT2A receptor binding and social communication in adults with Asperger's syndrome: an invivo SPECT study. Am J Psychiatry 2006, 163(5):934-936.
25. Goldberg J., Anderson G.M., Zwaigenbaum L., et al. Cortical serotonin type-2 receptor density in parents of children with autism spectrum disorders. JAutism Dev Disord 2009, 39(1):97-104.
26. Silva A.E., Vayego-Lourenco S.A., Fett-Conte A.C., et al. Tetrasomy 15q11-q13 identified by fluorescence in situ hybridization in a patient with autistic disorder. Arq Neuropsiquiatr 2002, 60(2-A):290-294.
27. Menold M.M., Shao Y., Wolpert C.M., et al. Association analysis of chromosome 15 gabaa receptor subunit genes in autistic disorder. JNeurogenet 2001, 15(3-4):245-259.
28. Buxbaum J.D., Silverman J.M., Smith C.J., et al. Association between a GABRB3 polymorphism and autism. Mol Psychiatry 2002, 7(3):311-316.
29. Soejima H., Wagstaff J. Imprinting centers, chromatin structure, and disease. JCell Biochem 2005, 95:226-233.
30. Wagstaff J., Knoll J.H., Fleming J., et al. Localization of the gene encoding the GABAA receptor beta 3 subunit to the Angelman/Prader-Willi region of human chromosome 15. Am J Hum Genet 1991, 49:330-337.
31. Holopainen I.E., Metsahonkala E.L., Kokkonen H., et al. Decreased binding of [11C]flumazenil in Angelman syndrome patients with GABA(A) receptor beta3 subunit deletions. Ann Neurol 2001, 49(1):110-113.
32. Lucignani G., Panzacchi A., Bosio L., et al. GABA A receptor abnormalities inPrader-Willi syndrome assessed with positron emission tomography and [11C]flumazenil. Neuroimage 2004, 22(1):22-28.
33. Pearl P.L., Gibson K.M., Quezado Z., et al. Decreased GABA-A binding on FMZ-PET in succinic semialdehyde dehydrogenase deficiency. Neurology 2009, 73(6):423-429.
34. Dager S.R., Corrigan N.M., Richards T.L., et al. Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders. Top Magn Reson Imaging 2008, 19(2):81-96.
35. van der Knaap M.S., van der Grond J., van Rijen P.J., et al. Age-dependent changes in localized proton and phosphorus MR spectroscopy of the brain. Radiology 1990, 176:509-515.
36. Huppi P.S., Posse S., Lazeyras F., et al. Magnetic resonance in preterm and term newborns: 1H-spectroscopy in developing human brain. Pediatr Res 1991, 30:574-578.
37. Kreis R., Ernst T., Ross B.D. Development of the human brain: invivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med 1993, 30:424-437.
38. Chugani D.C., Sundram B.S., Behen M., et al. Evidence of altered energy metabolism in autistic children. Prog Neuropsychopharmacol Biol Psychiatry 1999, 23(4):635-641.
39. Otsuka H., Harada M., Mori K., et al. Brain metabolites in the hippocampus-amygdala region and cerebellum in autism: an 1H-MR spectroscopy study. Neuroradiology 1999, 41(7):517-519.
40. Hisaoka S., Harada M., Nishitani H., et al. Regional magnetic resonance spectroscopy of the brain in autistic individuals. Neuroradiology 2001, 43(6):496-498.
41. Murphy D.G., Critchley H.D., Schmitz N., et al. Asperger syndrome: a proton magnetic resonance spectroscopy study of brain. Arch Gen Psychiatry 2002, 59(10):885-891.
42. Friedman S.D., Shaw D.W., Artru A.A., et al. Regional brain chemical alterations in young children with autism spectrum disorder. Neurology 2003, 60(1):100-107.
43. Fayed N., Modrego P.J. Comparative study of cerebral white matter in autism and attention-deficit/hyperactivity disorder by means of magnetic resonance spectroscopy. Acad Radiol 2005, 12:566-569.
44. DeVito T.J., Drost D.J., Neufeld R.W., et al. Evidence for cortical dysfunction in autism: a proton magnetic resonance spectroscopic imaging study. Biol Psychiatry 2007, 61(4):465-473.
45. Friedman S.D., Shaw D.W., Artru A.A., et al. Gray and white matter brain chemistry in young children with autism. Arch Gen Psychiatry 2006, 63:786-794.
46. Kleinhans N.M., Schweinsburg B.C., Cohen D.N., et al. N-acetyl aspartate in autism spectrum disorders: regional effects and relationship to fMRI activation. Brain Res 2007, 1162:85-97.
47. Endo T., Shioiri T., Kitamura H., et al. Altered chemical metabolites in the amygdala-hippocampus region contribute to autistic symptoms of autism spectrum disorders. Biol Psychiatry 2007, 62(9):1030-1037.
48. Hardan A.Y., Minshew N.J., Melhem N.M., et al. An MRI and proton spectroscopy study of the thalamus in children with autism. Psychiatry Res 2008, 163(2):97-105.
49. Fujii E., Mori K., Miyazaki M., et al. Function of the frontal lobe in autistic individuals: a proton magnetic resonance spectroscopic study. JMed Invest 2010, 57(1-2):35-44.
50. Gabis L., Wei H., Azizian A., et al. 1H-magnetic resonance spectroscopy markers of cognitive and language ability in clinical subtypes of autism spectrum disorders. JChild Neurol 2008, 23(7):766-774.
51. Zeegers M., van der Grond J., van Daalen E., et al. Proton magnetic resonance spectroscopy in developmentally delayed young boys with or without autism. JNeural Transm 2007, 114:289-295.
52. Vasconcelos M.M., Brito A.R., Domingues R.C., et al. Proton magnetic resonance spectroscopy in school-aged autistic children. JNeuroimaging 2008, 18(3):288-295.
53. Page L.A., Daly E., Schmitz N., et al. Invivo 1H-magnetic resonance spectroscopy study of amygdala-hippocampal and parietal regions in autism. Am J Psychiatry 2006, 163(12):2189-2192.
54. Bernardi S., Anagnostou E., Shen J., et al. Invivo 1H-magnetic resonance spectroscopy study of the attentional networks in autism. Brain Res 2011, 1380:198-205.